Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Interview with Dr. McFarland - Fort Worth Report

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Mar 15, 2022 5:29pm

250 Views

Post# 34516614

RE:RE:RE:New Interview with Dr. McFarland - Fort Worth Report

Very interesting thought, any ideas whether they will look for buyout or just continue business? Hope if there is a buyout they value this technology high enough. If there is not a buyout, we could follow in the footsteps of other small biopharma companies that hit it big. Very promising time coming soon, after listening to the advantages of our technology in previous posts.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China